From enabling individuals with limited mobility to control prosthetic limbs using brain signals, to treating depression through non-invasive stimulation, neurotechnology is reshaping what’s possible in healthcare and human performance.On NeuroTech Matters, we’re diving deep into this fast-evolving field, exploring brain-computer interfaces, neurostimulation, cognitive prosthetics, and AI-powered digital therapeutics.🌐 Neurotech is already transforming how we approach: • Neurodegenerative diseases like Alzheimer’s and Parkinson’s • Mental health conditions including depression and PTSD • Spinal cord injuries, epilepsy, chronic pain, and more✨ We’re also spotlighting next-gen breakthroughs, from wearable EEG headbands to neural digital twins and gene therapy tools like optogenetics.But innovation must go hand-in-hand with responsibility. That’s why we’re also talking about ethical challenges, privacy, accessibility, and the line between healing and enhancement.👉 Follow NeuroTech Matters to stay updated on how neuroscience, tech, and ethics are converging to shape the future of brain–machine interaction.#Neurotechnology #NeuroTechMatters #BCI #BrainComputerInterfaces #MentalHealthTech #DigitalTherapeutics #Neuroscience #TechForGood #Bioethics #Neuromodulation

Whether you’re a first-time founder or just VC-curious, here’s your no-fluff guide to the key stages of startup funding:1. Pre-SeedThis is where it all begins.You have an idea, maybe an early prototype, and tons of grit.Funding usually comes from personal savings, friends, family, or angel investors.At this point, investors bet on you, not just the product.2. SeedYou’re gaining traction, some users, maybe even early revenue.Now you need capital to build your team, refine your product, and find product-market fit.Think of it as watering the seed that’s just started to sprout.3. Series A/B/C…You’ve validated the idea, now it’s time to scale. • Series A: Grow your user base and sharpen your business model • Series B: Enter new markets and expand operations • Series C+: Double down, dominate, acquire othersEach round means bigger checks, more expectations, and stronger KPIs.4. Bridge RoundThis is a stop-gap.It’s temporary funding to get you from one major round to the next.Bridge rounds help you hit critical milestones without slowing down.Often raised via SAFEs or convertible notes.5. Follow-on InvestmentYour early investors are back for more.Follow-on funding shows confidence, they’re doubling down on your growth.It’s a great signal to the market that you’re on the right track.6. Exit StrategyThe finish line, or a new beginning.Exits include: • IPO: Going public • Acquisition: Getting bought • Secondary Sale: Selling shares to new investorsEvery investor wants one. You should be thinking about it, too.Closing CTA:Which stage resonates with you most, or feels like a mystery?Drop a comment and let’s unpack it together.#VentureCapital #StartupFunding #Founders #Startups #Entrepreneurship #SeedFunding #SeriesA #ExitStrategy

Raising capital is about more than just pitching—it’s about speaking the language of investors. In Part 1, we covered the core funding journey terms. Today, let’s dive into Part 2 of the Essential Glossary—the terms that come up as you scale, manage teams, and navigate multiple rounds.🔹 Option Pool – A reserved percentage of equity for future hires (often 10-20%). Ensure you know how this impacts your cap table.🔹 Vesting – How founders’ and employees’ equity ownership is earned over time (e.g., 4 years with a 1-year cliff).🔹 Pro-rata Rights – Gives early investors the right to maintain their ownership % in future rounds.🔹 Liquidation Preference – Defines who gets paid first (and how much) in an exit event. Commonly 1x for investors.🔹 Drag-Along Rights – Allows majority shareholders to force minority holders to sell if an acquisition deal is approved.🔹 Board Composition – Who holds seats at the table for key decisions? Understand how investor seats vs. founder seats are negotiated.🔹 Anti-dilution Clause – Protects investors from ownership loss if new shares are issued at a lower valuation.These terms shape negotiation dynamics as your startup grows. Knowing them helps protect your vision.Check out Part 2 of the visual glossary soon—and don’t forget to share this with a founder on their fundraising journey!#StartupGlossary #VentureCapital #FounderToolkit #OptionPool #LiquidationPreference #ScalingStartups #NeuroTechMatters #Entrepreneurship #DeepTech #Innovation #ChaanakyaCapital

For early-stage founders, the world of venture capital can feel like learning a new language. Whether you're prepping for your first fundraising round or scaling to your Series A, knowing the right terms helps you negotiate with confidence and build lasting investor relationships.That’s why we’ve put together Part 1 of the Essential Glossary for VCs and Founders, a simple, visual timeline covering key concepts that come into play during a startup’s journey.🔹 Exit Strategy - Every journey starts with the end in mind (IPO, acquisition).🔹 Cap Table - Know who owns what from day one.🔹 Burn Rate & Runway -Your financial lifeline, monitor it closely.🔹 Term Sheet & Valuation - The core of investment negotiations.🔹 SAFE & Convertible Note- Flexible funding instruments for early-stage capital.🔹 Dilution- Understand how new funding affects your stake.🔹 Due Diligence- The final gate before a deal closes.These aren’t just buzzwords, they’re building blocks. Understanding them can make or break critical moments in your startup’s life cycle.Check out the visual timeline below, and feel free to share with someone navigating their founder journey!Stay tuned for Part 2 where I’ll cover terms like vesting, option pools, pro-rata rights, and more!#StartupGlossary #VentureCapital #FoundersToolkit #StartupLife #CapTable #FundingJourney #Entrepreneurship #Startups #DeepTech #NeuroTechMatters #Innovation #ChaanakyaCapital

Inspired by, Original post: https://lnkd.in/g596veqc As the U.S. regulatory landscape becomes increasingly complex for novel neurotechnologies, early-stage startups are exploring Europe for their clinical trials. The European Clinical Trials Regulation (CTR) has introduced harmonized and streamlined processes, making trial approvals faster and more predictable.​The €66.8M READI initiative is investing in trial readiness and diversity across the EU. Spain, for instance, has seen a significant increase in trial activity due to proactive infrastructure investments. This shift presents both challenges and opportunities. While Europe aims to attract more trials by addressing existing bottlenecks, startups must navigate the evolving landscape to capitalize on these developments.​Let's talk about it! What are your thoughts?#NeuroTech #ClinicalTrials #MedTech #StartupFunding #Chaanakyacapital #HealthcareInnovation #EUHealth #RegulatoryStrategy #AIinHealth #VC #venturecapital #angelinvesotor #investment #founder

Neurotechnology startups sit at the crossroads of science, medicine, and engineering, so traditional metrics don’t always apply.So what do VCs actually look for?1. Scientific Validity & DifferentiationIs there strong preclinical/clinical data? Is the tech novel, and protected by IP?2. Market PotentialCan it scale beyond a niche? VCs favor startups targeting high-burden diseases (like epilepsy, stroke, neurodegeneration). 3. Team StrengthFounders who combine neuroscience, engineering, and business instincts win points- especially with top-tier advisors. 4. Path to RevenueClear regulatory plan, go-to-market strategy, and early signs of adoption or reimbursement potential. 5. Vision + GritThe long game requires clarity, conviction, and resilience. VCs fund teams, not just tech.#NeuroTechMatters #VentureCapital #NeuroStartups #BrainTech #HealthTech #DeepTech #InvestSmart #Angelinvestor #Founder

We’re thrilled to launch a new blog at the intersection of neuroscience, technology, and venture capital.Why now? Because neurotechnology is no longer a futuristic dream—it’s shaping the present. From brain-computer interfaces to AI-driven diagnostics, the neurotech industry is booming with innovation, yet remains underrepresented in mainstream conversations around tech and investing.Neuro Tech Matters is our effort to change that.We'll be covering everything from market trends and startup stories to in-depth profiles of investors, founders, and visionaries like Johana Vega and Varun Turlapati. Whether you're a researcher, entrepreneur, investor, or simply neuro-curious, this space is for you.We believe the brain is the next frontier and we want to spotlight the people, ideas, and capital pushing boundaries.Follow us. Share your thoughts. Join the conversation.Because neuro tech matters.#Neurotechnology #VentureCapital #BrainTech #Startups #NeuroTechMatters #Innovation #TechTrends #InvestInNeuro #BCI #DeepTech #FutureOfHealth #NeuroStartups #HealthTech #DigitalHealth #FoundersToWatch #AIInMedicine #VCInsights #FutureInTech